Drug Approvals
Moderna Shares Surge on Promising Vaccine Results
Let's check the charts and indicators.
Fed Heads: All Together Now, Market Outlook, Earnings, Lilly, AbbVie Talk Drugs
Why does the Fed as a whole appear to be unwilling to consider that they might be mistaken in the pace of their aggression?
NovoCure Gaps Sharply Higher for a Breakout: How to Play It
Let's check out the charts and indicators of both NovoCure and Zai Lab.
Expect Biotech to Head Higher in 2023
Let's dip into the biotech mailbag as the year comes to an end.
Pfizer May Not Be a Growth Play But It's a Good Stock for Tough Times
PFE is fundamentally sound and certainly not overvalued.
Merck's Stock Could Keep Climbing Higher
Here's what traders should do now.
Replimune Breaks Out: Could Rise 30% From Here
Let's check out the charts and indicators of this biotech name.
Is the Time Right to Buy Amgen After the Horizon Therapeutics Deal?
Here's the play traders can make.
Pacific Biosciences Has Made a Bottom Pattern: Prices to Watch
The stock bottomed in June/July and have worked higher.
BioVie Shares Higher on Alzheimer Data
Let's check the charts but be prepared for volatility.